testimonial 12
“I would like to let you know my deepest gratitude to all your help on my grants. I learned a lot from you.”
Immunology
Cancer Immunology Training Program
PROJECT SUMMARY: Interest in cancer immunology has never been more intense. Breakthrough observations with inhibitory receptor blockade, combined with ground breaking advances in the use of chimeric antigen receptor (CAR)-modified T cell adoptive therapies have highlighted the critical need to further basic and translation research in cancer immunology. While the pipeline of potential immunotherapeutic targets is growing, the pipeline of future cancer immunologists is limited, in part due to significant demand in industry and academia.
Immunoprevention and Immunosurveillance of Human Non-Viral Cancers
My research over the last 25 years has been unique in providing data and scientific leadership on the path towards a prevention vaccine for non-viral cancers. Cancer immunotherapy is now a reality and both academia and pharmaceutical companies are focusing on the next best treatment for advanced cancer. This is unfortunate given the fact that even as successful as some cancer immunotherapy was recently shown to be, it helps only a fraction of patients and cures even a smaller subset of those.